Biolux Research, a Vancouver, Canada-based developer of innovative Light Accelerated Orthodontic products, closed a $14M Series A funding round.
The round was led by Venrock and joined by Correlation Ventures, insiders and other investors.
Biolux manufactures OrthoPulse®, an FDA cleared orthodontic device currently being sold in the United States, Europe, and Asia. OrthoPulse is a non-invasive technology which, when used ten minutes each day, can accelerate orthodontic treatment.
Coincident with the completion of the round, Biolux announced that David Thrower has been appointed Chief Executive Officer of the company.
Over the last 25 years, Thrower has held executive leadership roles in a variety of medical device companies. The majority of his career has been spent driving growth in businesses that reside at the intersection of the consumer and medical devices spaces. He started his career at Bain & Company.
More recently his roles have included VP of Global Marketing at Align Technology, CEO of InSound Medical, Asante Solutions and BAROnova, Inc. Biolux earned a BS in Mathematical and Computational Sciences from Stanford University and an MBA from Harvard Business School.
FinSMEs
30/04/2019